The Journal of Medical Microbiology, Vol 47, Issue 10 871-877, Copyright © 1998 by Society for General Microbiology

JOURNAL ARTICLE

Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis

I. Sugawara, H. Yamada, Y. Kazumi, N. Doi, K. Otomo, T. Aoki, S. Mizuno, T. Udagawa, Y. Tagawa and Y. Iwakura
Molecular Pathology Division, Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, Tokyo.

To gain a better understanding of the pathological role of interferon-gamma (IFN-gamma) in specific granuloma formation, IFN-gamma gene-deficient mice (BALB/c and C57BL/6) were produced. The IFN-gamma gene in embryonic stem (ES) cells was disrupted by inserting the beta-galactosidase gene (lacZ) and the neomycin resistance gene (neo) at the translation initiation site in exon 1 by homologous recombination. Six-week-old IFN-gamma-deficient and wild-type mice were inoculated with 10(3)-10(7) bacilli of various strains of Mycobacterium tuberculosis (Kurono, H37Rv, H37Ra and BCG Pasteur) through their tail veins. The mice were examined 7 weeks later for granuloma formation. The avirulent BCG Pasteur and H37Ra strains (10(3)-10(4) bacilli/ml) induced granulomas in the spleen, liver and lungs of IFN-gamma-deficient mice. The granulomas consisted of epithelioid macrophages and Langhans multinucleate giant cells, but lacked caseous necrosis. The virulent Kurono and H37Rv strains induced disseminated abscesses but not granulomas in various organs of IFN-gamma-deficient mice and Mac-3-positive macrophages were not detected in the abscess lesions. These results suggest that IFN-gamma may be primarily responsible for macrophage activation and that other factor(s) may be involved in the granuloma formation mechanism.

This article has been cited by other articles:

				R. L. Hunter, M. Olsen, C. Jagannath, and J. K. Actor Trehalose 6,6'-Dimycolate and Lipid in the Pathogenesis of Caseating Granulomas of Tuberculosis in Mice Am. J. Pathol., April 1, 2006; 168(4): 1249 - 1261. [Abstract] [Full Text] [PDF]

				A. J. M. Lenaerts, V. Gruppo, J. V. Brooks, and I. M. Orme Rapid In Vivo Screening of Experimental Drugs for Tuberculosis Using Gamma Interferon Gene-Disrupted Mice Antimicrob. Agents Chemother., February 1, 2003; 47(2): 783 - 785. [Abstract] [Full Text] [PDF]

				I. Sugawara, H. Yamada, and S. Mizuno Relative importance of STAT4 in murine tuberculosis J. Med. Microbiol., January 1, 2003; 52(1): 29 - 34. [Abstract] [Full Text] [PDF]

				I. SUGAWARA, T. UDAGAWA, S.C. HUA, M. REZA-GHOLIZADEH, K. OTOMO, Y. SAITO, and H. YAMADA Pulmonary granulomas of guinea pigs induced by inhalation exposure of heat-treated BCG Pasteur, purified trehalose dimycolate and methyl ketomycolate J. Med. Microbiol., February 1, 2002; 51(2): 131 - 137. [Abstract] [Full Text] [PDF]

				A. Billiau and P. Matthys Modes of action of Freund's adjuvants in experimental models of autoimmune diseases J. Leukoc. Biol., December 1, 2001; 70(6): 849 - 860. [Abstract] [Full Text] [PDF]

				H. Yamada, S. Mizuno, M. Reza-Gholizadeh, and I. Sugawara Relative Importance of NF-kappa B p50 in Mycobacterial Infection Infect. Immun., November 1, 2001; 69(11): 7100 - 7105. [Abstract] [Full Text] [PDF]

				I. Sugawara, S. Mizuno, H. Yamada, M. Matsumoto, and S. Akira Disruption of Nuclear Factor-Interleukin-6, a Transcription Factor, Results in Severe Mycobacterial Infection Am. J. Pathol., February 1, 2001; 158(2): 361 - 366. [Abstract] [Full Text] [PDF]

				I. Sugawara, H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, and S. Akira Role of Interleukin-18 (IL-18) in Mycobacterial Infection in IL-18-Gene-Disrupted Mice Infect. Immun., May 1, 1999; 67(5): 2585 - 2589. [Abstract] [Full Text] [PDF]

				J. A. M. Langermans, P. Andersen, D. van Soolingen, R. A. W. Vervenne, P. A. Frost, T. van der Laan, L. A. H. van Pinxteren, J. van den Hombergh, S. Kroon, I. Peekel, et al. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: Implications for primate models in tuberculosis vaccine research PNAS, September 25, 2001; 98(20): 11497 - 11502. [Abstract] [Full Text] [PDF]